Overview
- Comprehensive coverage of current and promising modalities for psychiatric and metabolic diseases
- Includes novel, informative case studies
- Written by a multidisciplinary panel of experts
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (17 chapters)
-
Front Matter
-
Foundations of Ethics in Clinical Neuroinnovation
-
Front Matter
-
-
Special Topics in Clinical Neuroinnovation
-
Front Matter
-
-
Neuroethics and Innovation: Inquiry Informed by the Roberts Valence Model
-
Front Matter
-
Keywords
About this book
New ways of understanding the brain – its nature, its capacities, its function, and its dysfunction – hold great promise for human wellbeing. Novel therapeutics spurred by this understanding have important roles addressing many clinical conditions, including Alzheimer Disease, depression, addiction, and obsessive-compulsive disorder. This unique title explores a wide range of groundbreaking sciences and clinical practices for brain-based conditions, including deep brain stimulation, optogenetics, technology-delivered therapies, predictive testing, and new clinical uses of ketamine, cannabis, and other psychoactive substances.
An introduction to the imperative to develop new treatments for devastating brain disorders and the state of current therapeutics in psychiatry, addiction, and behavioral disorders is presented, and chapters from leading physician-scientists and neuroethicists outline the clinical and the ethical issues arising in innovation and in the creation of new therapeutics for brain diseases. Written by renowned thought leaders in their fields, the book presents tightly written contributions on novel qualitative and quantitative data from stakeholders in the field, including neuroscientist-clinicians, people living with mental illness and/or addictions, and oversight/policy stakeholders.
Concise, anticipatory, and centered on the principles governing human biomedical research and innovation in developing novel therapeutics for brain disorders, Ethics and Clinical Neuroinnovation will be of great value to clinicians, researchers, and students from a vast array of backgrounds, including neuroethics, neuroscience, psychology, psychiatry, philosophy, entrepreneurship, and the law.
Editors and Affiliations
About the editor
Laura Roberts, MD, MA, is Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Chair of the Department of Behavioral Sciences in the School of Medicine at Stanford University.
Bibliographic Information
Book Title: Ethics and Clinical Neuroinnovation
Book Subtitle: Fundamentals, Stakeholders, Case Studies, and Emerging Issues
Editors: Laura Weiss Roberts
DOI: https://doi.org/10.1007/978-3-031-14339-7
Publisher: Springer Cham
eBook Packages: Behavioral Science and Psychology, Behavioral Science and Psychology (R0)
Copyright Information: Springer Nature Switzerland AG 2023
Hardcover ISBN: 978-3-031-14338-0Published: 01 February 2023
Softcover ISBN: 978-3-031-14341-0Published: 02 February 2024
eBook ISBN: 978-3-031-14339-7Published: 31 January 2023
Edition Number: 1
Number of Pages: XII, 353
Number of Illustrations: 6 b/w illustrations, 16 illustrations in colour
Topics: Neurosciences, Neuropsychology, Neurology